Clinical Trial Update: Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD) [Phase 4]

View source ↗

Summary

This document reports the completion and posted results of a Phase 4 clinical trial evaluating pramipexole (Mirapex) for early treatment of Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Mirapex (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2010-01-26